News Updates

03

2025/07

Pooling Strength in Kuala Lumpur: Ushering in a New Chapter of Southeast Asian Cooperation — Bio-Thera Solutions Makes Its Debut in Southeast Asia

10

2025/06

Baike Biotech’s independently developed “Adsorbed Acellular DTP (Three-Component) Combined Vaccine” Has Initiated Phase III Clinical Trials. Baike Biotech’s independently developed “Adsorbed Acellular DTP (Three-Component) Combined Vaccine” Has Initiated Phase III Clinical Trials.

05

2025/06

Announcement by Changchun Beacon Biotechnology Co., Ltd. on the Voluntary Disclosure of the Approval of the Clinical Trial Application for the Recombinant Shingles Vaccine (CHO Cells)

15

2025/05

“May 15 National Investor Protection Public Awareness Day” 2025

14

2025/05

Baike Bio’s 2024 Annual Report and First Quarter 2025 Report

28

2025/04

Writing a New Chapter in Collaborative Development and Building a Fortress of Public Health — Jiangsu Provincial Center for Disease Control and Prevention and Bio-Thera Solutions Discuss Public Health Cooperation

On the afternoon of April 23, the Jiangsu Provincial Center for Disease Prevention and Control held a strategic cooperation symposium in Nanjing with Changchun Beacon Biotechnology Co., Ltd. (hereinafter referred to as “Beacon Biotech”).
< 1234...26 >

Sorry，当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry，The current column has no content!

You can view other columns or return Home